Inhibition of Apolipoprotein E-Related Neurotoxicity by Glycosaminoglycans and Their Oligosaccharides
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Apolipoprotein E (apoE) has been genetically linked to late-onset Alzheimer's disease (AD). The role of this lipid-transport protein in AD remains to be established. One hypothesis is that apoE, particularly the apoE4 isoform, may have neurotoxic effects as demonstrated using apoE-related synthetic peptides and the N-terminal fragment of apoE. ApoE is a heparan-sulfate binding protein, and apoE peptide neurotoxicity can be blocked by heparin and prevented by degrading heparan sulfate or inhibiting its biosynthesis. The possibility that heparin inhibition of toxicity is mediated by a specific oligosaccharide sequence was investigated using a bioassay to determine the inhibition of apoE peptide toxicity by glycosaminoglycans and purified glycosaminoglycan oligosaccharides. Studies on modified heparins showed that the presence of N-sulfo groups and either 2- or 6-O sulfo groups were required for inhibition of toxicity. Heparin oligosaccharides with eight or more saccharide residues with seven O-sulfo groups and four N-sulfo groups exhibited potent inhibition. Larger oligosaccharides, and heparin and heparan sulfate polymers, afforded comparable, or somewhat better, protective effects but also caused clumping and detachment of cells when administrated alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
William Rebeck, G., Reiter, J. S., Strickland, D. K., & Hyman, B. T. (1993) · Neuron · doi:10.1016/0896-6273(93)90070-8 · Cited by 1,107
Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid
Wisniewski, T., & Frangione, B. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90444-c · Cited by 802
Mahley, R. W., & Ji, Z.-S. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33334-4 · Cited by 693
The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments.
Innerarity, T. L., Friedlander, E. J., Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44180-9 · Cited by 276
Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3.
Weisgraber, K. H., Rall, S. C., Mahley, R. W., Milne, R. W., Marcel, Y. L., & Sparrow, J. T. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35898-2 · Cited by 240
Lalazar, A., Weisgraber, K. H., Rall, S. C., Giladi, H., Innerarity, T. L., Levanon, A. Z., Boyles, J. K., Amit, B., Gorecki, M., & Mahley, R. W. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68957-4 · Cited by 209
Tolar, M., Keller, J. N., Chan, S., Mattson, M. P., Marques, M. A., & Crutcher, K. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-16-07100.1999 · Cited by 148
Self-citation
Research works printed but not linked: 47
- Cruts M., 1998, 30, 560−565
- Roses A. D., 1995, Am. J. Hum. Genet., 57, A202
- Mahley R. W., 1988, Science 240, 622−630
- Weisgraber K. H., 1994, Adv. Prot. Chem. 45, 249−302
- Beffert U., 1998, Brain Res. Rev., 27, 10.1016/S0165-0173(98)00008-3 · DOI · Paper page
- Weisgraber K. H., 1996, FASEB J. 1485−1494.
- Wilson C., 1991, Science 252
- Dong L. M., 1994, J. Biol. Chem., 269
- Das H. K., 1985, J. Biol. Chem., 260
- Mahley R. W., 1995, in The Metabolic and Molecular Basis of Inherited Disease
- Luc G., 1994, Arterioscler. Thromb. 14, 1412−1419
- Corder E. H., 1994, Nat. Genet. 7, 180−184
- Saunders A. M., 1993, Neurology 43, 1467−1472
- Strittmatter W. J., 1993, Proc. Natl. Acad. Sci. U.S.A. 90
- Laskowitz D. T., 1998, Alzheimer's Rep., 1, 12
- Strittmatter W. J., 1994, Exp. Neurol. 125, 163−171
- Strittmatter, W. J., Saunders, A. M., Goedert, M., Weisgraber, K. H., Dong, L., Jakes, R., Huang, D. Y., Pericak-Vance, M., Schmechel, D., and Roses, A. D.Proc. Natl. Acad. Sci. U.S.A. 91, 11183−11186. · DOI · Paper page
- Miyata M., 1996, Nat. Genet., 14, 61, 10.1038/ng0996-55 · DOI · Paper page
- Nathan B. P., 1994, Science 264, 850−852
- Poirier J., 1994, Trends Neurosci. 17, 525−530
- Pitas R. E., 1998, Biochem. Soc. Trans., 26, 10.1042/bst0260257 · DOI · Paper page
- Nathan B. P., 2002, Brain Res., 928, 105, 10.1016/S0006-8993(01)03367-4 · DOI · Paper page
- Pedersen W. A., 2000, J. Neurochem., 74, 10.1046/j.1471-4159.2000.0741426.x · DOI · Paper page
- Rebeck G. W., 1993, Neuron 11, 575−580
- Schmechel D. E., 1993, Proc. Natl. Acad. Sci. U.S.A. 90, 9649−9653
- Crutcher K. A., 1994, Exp. Neurol. 130, 120−126
- Marques M. A., 1996, eport 7, 2529−2532.
- Marques M. A., 1997, Alzheimer Res., 3, 16
- Jordán J., 1998, J. Neurosci., 18, 10.1523/JNEUROSCI.18-01-00195.1998 · DOI · Paper page
- Michikawa M., 1998, J. Neurosci. Res., 54, 67, 10.1002/(SICI)1097-4547(19981001)54:1<58::AID-JNR7>3.0.CO;2-G · DOI · Paper page
- Hashimoto Y., 2000, J. Neurosci., 20, 10.1523/JNEUROSCI.20-22-08401.2000 · DOI · Paper page
- Weisgraber K. H., 1983, J. Biol. Chem., 258
- Tolar M., 1997, J. Neurosci., 17, 10.1523/JNEUROSCI.17-15-05678.1997 · DOI · Paper page
- Mahley R. W., 1999, J. Lipid Res., 40, 16
- Pervin A., 1995, Glycobiology, 5, 95, 10.1093/glycob/5.1.83 · DOI · Paper page
- Yang H. O., 2000, Glycobiology 10, 1033−1039
- Clay M. A., 1995, Biochemistry 34, 11142−11151
- Dong J., 2001, Biochemistry 40, 2826−2834
- Casu B., 1988, Trends Biochem. Sci. 13, 221−225
- Das S. K., 2001, Angew
- Yamada S., 1995, J. Biol. Chem., 270
- Larnkjaer A., 1995, Carbohydr. Res., 266, 52, 10.1016/0008-6215(94)00247-D · DOI
- Peters Libeu C., 2001, J. Biol. Chem., 276
- Yu G., 2000, Thromb. Res. 100, 549−556
- Lyon M., 1994, J. Biol. Chem., 269
- Linhardt R. J., 1988, J. Biol. Chem., 263, 10.1016/S0021-9258(18)37675-0 · DOI
- Abbreviations AD, Alzheimer's disease
Cited by
2003 Claude S. Hudson Award Address in Carbohydrate Chemistry. Heparin: Structure and Activity
Linhardt, R. J. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030176m · Cited by 493
Self-citationBergamaschini, L., Rossi, E., Storini, C., Pizzimenti, S., Distaso, M., Perego, C., De Luigi, A., Vergani, C., & Grazia De Simoni, M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0550-04.2004 · Cited by 146
Two-step Mechanism of Binding of Apolipoprotein E to Heparin
Futamura, M., Dhanasekaran, P., Handa, T., Phillips, M. C., Lund-Katz, S., & Saito, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411719200 · Cited by 91
Structural characterization of human liver heparan sulfate
Vongchan, P., Warda, M., Toyoda, H., Toida, T., Marks, R. M., & Linhardt, R. J. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.09.007 · Cited by 65
Self-citationYamauchi, Y., Deguchi, N., Takagi, C., Tanaka, M., Dhanasekaran, P., Nakano, M., Handa, T., Phillips, M. C., Lund-Katz, S., & Saito, H. (2008) · Biochemistry · doi:10.1021/bi8003999 · Cited by 53
Metadata
- Authors
- Bazin, H. G., Marques, M. A., Owens, A. P., Linhardt, R. J., & Crutcher, K. A.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2002-06-01
- Volume
- 41
- Issue
- 25
- Pages
- 8203-8211
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2130326720
- Cited by
- 22
- References
- 7
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.